Add Company
Join Now

Bolden Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Bolden Therapeutics's estimated annual revenue is currently $697.5k per year.(i)
  • Bolden Therapeutics's estimated revenue per employee is $77,500

Employee Data

  • Bolden Therapeutics has 9 Employees.(i)
  • Bolden Therapeutics grew their employee count by 0% last year.

Bolden Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Director ResearchReveal Email/Phone
3
Research Co-OpReveal Email/Phone
4
Executive ChairmanReveal Email/Phone
5
Associate ScientistReveal Email/Phone
6
Associate ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1M13-19%N/AN/A
#2
$0.8M5-29%N/AN/A
#3
$0.9M620%N/AN/A
#4
$0.8M50%N/AN/A
#5
$0.9M6-14%N/AN/A
#6
$0.7M90%N/AN/A
#7
$1.1M70%N/AN/A
#8
$1.9M120%N/AN/A
#9
$14.9M9657%N/AN/A
#10
$1.4M90%N/AN/A
Add Company

What Is Bolden Therapeutics?

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke. The company’s scientific founders have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons (neurogenesis) in the adult brain. In a proprietary mouse model Bolden has established a proof-of-concept of this approach to increase neurogenesis and enhance hippocampal-dependent memory. The company is actively developing antisense oligonucleotide and monoclonal antibody therapeutics to modulate this pathway.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$697.5k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M9N/AN/A
#2
$0.5M90%N/A
#3
$0.7M913%N/A
#4
$0.7M90%N/A
#5
$0.7M9-10%N/A